Company profile
Sproutly Canada Inc.
OTC: SRUTF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#991 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 30
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, workforce scale · ↓ market scale, return on assets
Methodology →Revenue TTM
$407.6k
Rev growth YoY (TTM)
+36.8%
Net income (FY)
-$12.3M
Employees
27
as of 2026-08-30
Market cap
$3.1k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$237.1k316.4k CAD2020
Net income-$12.3M-16.4M CAD2020
Operating income-$10.6M-14.1M CAD2020
Total assets$3.3M4.2M CAD2020
Liabilities$7.7M9.8M CAD2020
Equity-$4.4M-5.6M CAD2020
Revenue trend
FY2016 – FY2020 · USD
FY16
FY17
FY18
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Sproutly Canada Inc.’s revenue?
Sproutly Canada Inc. booked $237.1k in FY2020 revenue, contracting 66% year over year — slower than 85% of Healthcare companies we track, at a -5186.7% net margin.
Peers · Healthcare
Envoy Medical, Inc.33DWellness Center USA, Inc.——LiveWire Ergogenics, Inc.——Geron Corporation51DRegen BioPharma, Inc.35DBlueberries Medical Corp.32DKey facts
CEOArup Sen
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: SRUTF
Employees27
IPO date2018-07-10
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.